April 23, 2024
A new type of immunotherapy drug appears to be more effective than other approaches at stimulating the immune response, the results of a study published April 19 in Nature Biomedical Engineering show.
Combining the 'best of two worlds' to boost immunotherapy response in mice with breast cancer
April 23, 2024
Hot flashes are one of the most commonly discussed side effects of menopause, but the decline of ovarian hormones and its effect on the gut microbiome can also increase the risk of a variety of metabolic diseases, including obesity and cardiometabolic syndrome, according to a recent publication by Tzu-Wen Cross, assistant professor in Purdue University’s Department Nutrition Science.
PURDUE NUTRITION SCIENCE RESEARCHER UNCOVERS CONNECTION BETWEEN HORMONES, GUT MICROBIOME AND METABOLIC DYSFUNCTION COMMONLY SEEN IN POSTMENOPAUSAL WOMEN
April 23, 2024
As the world emerges from the COVID-19 pandemic, there is an urgent need to understand patient factors that may be used to predict the occurrence of severe cases and patient mortality.
Identification of predictive patient characteristics for assessing the probability of COVID-19 in-hospital mortality
April 22, 2024
Purdue University researchers are developing and validating a patent-pending treatment for incurable glioblastoma brain tumors. Glioblastomas are almost always lethal with a median survival time of 14 months. Traditional methods used against other cancers, like chemotherapy and immunotherapy, are often ineffective on glioblastoma.
Genetically engineering a treatment for incurable brain tumors
April 22, 2024
Scientists are developing and validating a patent-pending novel immunotherapy to be used against glioblastoma brain tumors. Glioblastomas are almost always lethal with a median survival time of 14 months. Traditional methods used against other cancers, like chemotherapy and immunotherapy, are often ineffective on glioblastoma.
Genetically engineering a treatment for incurable brain tumors
April 22, 2024
Researchers at The University of Texas MD Anderson Cancer Center have unveiled a groundbreaking method in immunotherapy drug development, utilizing engineered peptides that stimulate the body’s immune system to fight cancer more effectively. Published in Nature Biomedical Engineering, their study presents a promising leap forward in treating advanced breast cancer, showcasing enhanced tumor suppression and extended survival rates.
Breakthrough in Cancer Treatment: Novel Engineered Peptides Enhance Immunotherapy Efficacy
April 22, 2024
In a significant milestone for the Purdue Institute for Cancer Research (PICR), faculty, students and staff gathered at the Hansen Life Sciences Research Building on April 17 to honor seven awardees for their outstanding contributions to cancer research. PICR Director Andrew Mesecar delivered remarks emphasizing the importance of establishing the awards ceremony as a tradition and spoke about the distinct contributions each recipient had made to further the institute’s goal of conquering cancer.
First annual PICR Awards ceremony recognizes excellence in cancer research
April 21, 2024
In a new study published in Nature Biomedical Engineering, researchers at The University of Texas MD Anderson Cancer Center have developed a new method for creating immunotherapy drugs using engineered peptides. The study showed that the method improved tumor control and prolonged survival in preclinical models of locally advanced and metastatic breast cancer, both as a monotherapy and in combination with immune checkpoint inhibitors.
New study paves the way for advancements in immunotherapy drug development
April 12, 2024
D. Marshall Porterfield’s proposal for a lunar plant growth experiment was selected by NASA for the Artemis 3 moon mission. Read more about the experiment: Artemis 3 to include Space Lab’s LEAF Plant Science Experiment.
Dr. Porterfield and Colleagues’ Experiment Selected for Artemis 3 Mission
April 12, 2024
World Parkinson’s Day is an annual global healthcare event to recognize the cultural, economic, and social impact of Parkinson’s disease. This year, April 11 was designated as World Parkinson’s Day, which also focuses on advancing the acceptance, inclusion, and support of people affected by the disease. In recognition of the day, Purdue University spotlighted research by Dr. Jessica Fortin, assistant professor of basic medical sciences, physiology and pharmacology in the College of Veterinary Medicine’s Department of Basic Medical Sciences.
Purdue University Recognizes World Parkinson’s Day by Highlighting Research Led by PVM Scholar
